ANGLE Signs Agreement with Recursion Pharma to Expand Pharma Services Business

ANGLE Signs Agreement with Recursion Pharma to Expand Pharma Services Business

By, Admin 23 September 2024

Overview

ANGLE plc, a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, announced that it has signed an agreement with Recursion Pharmaceuticals, Inc. (Recursion), a leading clinical stage TechBio company decoding biology to radically improve lives.

The agreement is being initiated with a fully funded pilot study.  Further details of the agreement are confidential between the parties.

Statement from the CEO: ANGLE

Chief executive of ANGLE, Andrew Newland, commented: “Whilst the study is modest in size during the pilot phase, there is the potential for larger follow-on contracts in the event of a successful pilot study. Recursion has partnerships with multiple leading large pharma companies and this agreement, ANGLE’s fourth for 2024, further builds on the expansion of our large pharma services business.”

About the Company: ANGLE

  • ANGLE is a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology using a simple blood sample. 
  • ANGLE’s US FDA cleared and patent protected circulating tumour cell (CTC) harvesting technology known as the Parsortix PC1 System enables complete downstream analysis of the sample including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis.

ANGLE’s Commercial Side

  • ANGLE’s commercial businesses are focusing on diagnostic products and clinical services. 
  • Diagnostic products include the Parsortix system, associated consumables and assays. 
  • The clinical services business is offered through ANGLE’s GCLP-compliant laboratories.  
  • Services include custom made assay development and clinical trial testing for pharmaceuticals.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!